Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Leases (2019 - 2026)

Standard Biotools has reported Current Leases over the past 7 years, most recently at $5.5 million for Q4 2025.

  • Quarterly Current Leases rose 14.23% to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, up 14.23% year-over-year, with the annual reading at $5.5 million for FY2025, 14.23% up from the prior year.
  • Current Leases was $5.5 million for Q4 2025 at Standard Biotools, up from $5.1 million in the prior quarter.
  • Over five years, Current Leases peaked at $6.3 million in Q1 2025 and troughed at $2.9 million in Q3 2021.
  • The 5-year median for Current Leases is $3.9 million (2023), against an average of $4.3 million.
  • Year-over-year, Current Leases surged 155.27% in 2021 and then dropped 16.48% in 2025.
  • A 5-year view of Current Leases shows it stood at $3.1 million in 2021, then increased by 20.6% to $3.7 million in 2022, then increased by 17.41% to $4.3 million in 2023, then rose by 11.17% to $4.8 million in 2024, then rose by 14.23% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Current Leases are $5.5 million (Q4 2025), $5.1 million (Q3 2025), and $5.1 million (Q2 2025).